APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biosimilars of Rituximab

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Biosimilars of Rituximab Industry Growth and Trends Forecast to 2032

2 January 2026101 pages

Choose your research edition.

Industry ResearchBiosimilars of Rituximab Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Biosimilars of Rituximab Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Biosimilars of Rituximab Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biosimilars of Rituximab Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Biosimilars of Rituximab Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Biosimilars of Rituximab market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Biosimilars of Rituximab is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Biosimilars of Rituximab is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biosimilars of Rituximab is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Biosimilars of Rituximab include AryoGen Pharmed, Biocad, Cadila Pharmaceuticals, Celltrion, Dr Reddy’s Laboratories, Hetero Group, Innovent Biologics, Intas Biopharmaceuticals and Probiomed, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Biosimilars of Rituximab market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Biosimilars of Rituximab market size, estimates, and forecasts are presented in terms of sales volume (K Pcs) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Biosimilars of Rituximab market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Biosimilars of Rituximab.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Biosimilars of Rituximab market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Biosimilars of Rituximab Market by Company

AryoGen Pharmed

Biocad

Cadila Pharmaceuticals

Celltrion

Dr Reddy’s Laboratories

Hetero Group

Innovent Biologics

Intas Biopharmaceuticals

Probiomed

TRPharma

Viatris

Zenotech Laboratories

Amgen

Teva

Biosimilars of Rituximab Segment by Type

500mg

100mg

Other

Biosimilars of Rituximab Segment by Application

Hospital Pharmacy

Retail Pharmacy

Biosimilars of Rituximab Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biosimilars of Rituximab market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biosimilars of Rituximab and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biosimilars of Rituximab.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Biosimilars of Rituximab manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Biosimilars of Rituximab in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 500mg Table 2. Major Company of 100mg Table 3. Major Company of Other Table 4. Global Biosimilars of Rituximab Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Biosimilars of Rituximab Sales by Type (2021-2026) & (K Pcs) Table 6. Global Biosimilars of Rituximab Sales Market Share in Volume by Type (2021-2026) Table 7. Global Biosimilars of Rituximab Sales by Type (2021-2026) & (US$ Million) Table 8. Global Biosimilars of Rituximab Sales Market Share in Value by Type (2021-2026) Table 9. Global Biosimilars of Rituximab Price by Type (2021-2026) & (US$/Pcs) Table 10. Global Biosimilars of Rituximab Sales by Type (2027-2032) & (K Pcs) Table 11. Global Biosimilars of Rituximab Sales Market Share in Volume by Type (2027-2032) Table 12. Global Biosimilars of Rituximab Sales by Type (2027-2032) & (US$ Million) Table 13. Global Biosimilars of Rituximab Sales Market Share in Value by Type (2027-2032) Table 14. Global Biosimilars of Rituximab Price by Type (2027-2032) & (US$/Pcs) Table 15. North America Biosimilars of Rituximab Sales by Type (2021-2026) & (K Pcs) Table 16. North America Biosimilars of Rituximab Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Biosimilars of Rituximab Sales by Type (2021-2026) & (K Pcs) Table 18. Europe Biosimilars of Rituximab Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Biosimilars of Rituximab Sales by Type (2021-2026) & (K Pcs) Table 20. Asia-Pacific Biosimilars of Rituximab Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Biosimilars of Rituximab Sales by Type (2021-2026) & (K Pcs) Table 22. Latin America Biosimilars of Rituximab Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Biosimilars of Rituximab Sales by Type (2021-2026) & (K Pcs) Table 24. Middle East and Africa Biosimilars of Rituximab Sales by Type (2021-2026) & (US$ Million) Table 25. Biosimilars of Rituximab Industry Trends Table 26. Biosimilars of Rituximab Industry Drivers Table 27. Biosimilars of Rituximab Industry Opportunities and Challenges Table 28. Biosimilars of Rituximab Industry Restraints Table 29. Global Biosimilars of Rituximab Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Biosimilars of Rituximab Revenue Market Share by Company (2021-2026) Table 31. Global Biosimilars of Rituximab Sales by Company (2021-2026) & (K Pcs) Table 32. Global Biosimilars of Rituximab Sales Share by Company (2021-2026) Table 33. Global Biosimilars of Rituximab Market Price by Company (2021-2026) & (US$/Pcs) Table 34. Global Biosimilars of Rituximab Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Biosimilars of Rituximab Major Company Production Sites and Headquarters Table 36. Global Biosimilars of Rituximab Company, Product Type & Application Table 37. Global Biosimilars of Rituximab Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Biosimilars of Rituximab by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Biosimilars of Rituximab Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Biosimilars of Rituximab Sales by Region (2021-2026) & (K Pcs) Table 42. Global Biosimilars of Rituximab Sales Market Share in Volume by Region (2021-2026) Table 43. Global Biosimilars of Rituximab Sales by Region (2021-2026) & (US$ Million) Table 44. Global Biosimilars of Rituximab Sales Market Share in Value by Region (2021-2026) Table 45. Global Biosimilars of Rituximab Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 46. Global Biosimilars of Rituximab Sales by Region (2027-2032) & (K Pcs) Table 47. Global Biosimilars of Rituximab Sales Market Share in Volume by Region (2027-2032) Table 48. Global Biosimilars of Rituximab Sales by Region (2027-2032) & (US$ Million) Table 49. Global Biosimilars of Rituximab Sales Market Share in Value by Region (2027-2032) Table 50. Global Biosimilars of Rituximab Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2027-2032) Table 51. Global Biosimilars of Rituximab Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Biosimilars of Rituximab Sales by Application (2021-2026) & (K Pcs) Table 53. Global Biosimilars of Rituximab Sales Market Share in Volume by Application (2021-2026) Table 54. Global Biosimilars of Rituximab Sales by Application (2021-2026) & (US$ Million) Table 55. Global Biosimilars of Rituximab Sales Market Share in Value by Application (2021-2026) Table 56. Global Biosimilars of Rituximab Price by Application (2021-2026) & (US$/Pcs) Table 57. Global Biosimilars of Rituximab Sales by Application (2027-2032) & (K Pcs) Table 58. Global Biosimilars of Rituximab Sales Market Share in Volume by Application (2027-2032) Table 59. Global Biosimilars of Rituximab Sales by Application (2027-2032) & (US$ Million) Table 60. Global Biosimilars of Rituximab Sales Market Share in Value by Application (2027-2032) Table 61. Global Biosimilars of Rituximab Price by Application (2027-2032) & (US$/Pcs) Table 62. North America Biosimilars of Rituximab Sales by Application (2021-2026) & (K Pcs) Table 63. North America Biosimilars of Rituximab Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Biosimilars of Rituximab Sales by Application (2021-2026) & (K Pcs) Table 65. Europe Biosimilars of Rituximab Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Biosimilars of Rituximab Sales by Application (2021-2026) & (K Pcs) Table 67. Asia-Pacific Biosimilars of Rituximab Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Biosimilars of Rituximab Sales by Application (2021-2026) & (K Pcs) Table 69. Latin America Biosimilars of Rituximab Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Biosimilars of Rituximab Sales by Application (2021-2026) & (K Pcs) Table 71. Middle East and Africa Biosimilars of Rituximab Sales by Application (2021-2026) & (US$ Million) Table 72. AryoGen Pharmed Company Information Table 73. AryoGen Pharmed Business Overview Table 74. AryoGen Pharmed Biosimilars of Rituximab Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 75. AryoGen Pharmed Biosimilars of Rituximab Product Portfolio Table 76. AryoGen Pharmed Recent Development Table 77. Biocad Company Information Table 78. Biocad Business Overview Table 79. Biocad Biosimilars of Rituximab Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 80. Biocad Biosimilars of Rituximab Product Portfolio Table 81. Biocad Recent Development Table 82. Cadila Pharmaceuticals Company Information Table 83. Cadila Pharmaceuticals Business Overview Table 84. Cadila Pharmaceuticals Biosimilars of Rituximab Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 85. Cadila Pharmaceuticals Biosimilars of Rituximab Product Portfolio Table 86. Cadila Pharmaceuticals Recent Development Table 87. Celltrion Company Information Table 88. Celltrion Business Overview Table 89. Celltrion Biosimilars of Rituximab Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 90. Celltrion Biosimilars of Rituximab Product Portfolio Table 91. Celltrion Recent Development Table 92. Dr Reddy’s Laboratories Company Information Table 93. Dr Reddy’s Laboratories Business Overview Table 94. Dr Reddy’s Laboratories Biosimilars of Rituximab Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 95. Dr Reddy’s Laboratories Biosimilars of Rituximab Product Portfolio Table 96. Dr Reddy’s Laboratories Recent Development Table 97. Hetero Group Company Information Table 98. Hetero Group Business Overview Table 99. Hetero Group Biosimilars of Rituximab Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 100. Hetero Group Biosimilars of Rituximab Product Portfolio Table 101. Hetero Group Recent Development Table 102. Innovent Biologics Company Information Table 103. Innovent Biologics Business Overview Table 104. Innovent Biologics Biosimilars of Rituximab Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 105. Innovent Biologics Biosimilars of Rituximab Product Portfolio Table 106. Innovent Biologics Recent Development Table 107. Intas Biopharmaceuticals Company Information Table 108. Intas Biopharmaceuticals Business Overview Table 109. Intas Biopharmaceuticals Biosimilars of Rituximab Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 110. Intas Biopharmaceuticals Biosimilars of Rituximab Product Portfolio Table 111. Intas Biopharmaceuticals Recent Development Table 112. Probiomed Company Information Table 113. Probiomed Business Overview Table 114. Probiomed Biosimilars of Rituximab Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 115. Probiomed Biosimilars of Rituximab Product Portfolio Table 116. Probiomed Recent Development Table 117. TRPharma Company Information Table 118. TRPharma Business Overview Table 119. TRPharma Biosimilars of Rituximab Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 120. TRPharma Biosimilars of Rituximab Product Portfolio Table 121. TRPharma Recent Development Table 122. Viatris Company Information Table 123. Viatris Business Overview Table 124. Viatris Biosimilars of Rituximab Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 125. Viatris Biosimilars of Rituximab Product Portfolio Table 126. Viatris Recent Development Table 127. Zenotech Laboratories Company Information Table 128. Zenotech Laboratories Business Overview Table 129. Zenotech Laboratories Biosimilars of Rituximab Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 130. Zenotech Laboratories Biosimilars of Rituximab Product Portfolio Table 131. Zenotech Laboratories Recent Development Table 132. Amgen Company Information Table 133. Amgen Business Overview Table 134. Amgen Biosimilars of Rituximab Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 135. Amgen Biosimilars of Rituximab Product Portfolio Table 136. Amgen Recent Development Table 137. Teva Company Information Table 138. Teva Business Overview Table 139. Teva Biosimilars of Rituximab Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 140. Teva Biosimilars of Rituximab Product Portfolio Table 141. Teva Recent Development Table 142. North America Biosimilars of Rituximab Market Size Growth Rate (CAGR) by Country (K Pcs): 2021 VS 2025 VS 2032 Table 143. North America Biosimilars of Rituximab Sales by Country (2021-2026) & (K Pcs) Table 144. North America Biosimilars of Rituximab Sales Market Share by Country (2021-2026) Table 145. North America Biosimilars of Rituximab Sales Forecast by Country (2027-2032) & (K Pcs) Table 146. North America Biosimilars of Rituximab Sales Market Share Forecast by Country (2027-2032) Table 147. North America Biosimilars of Rituximab Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. North America Biosimilars of Rituximab Market Size by Country (2021-2026) & (US$ Million) Table 149. North America Biosimilars of Rituximab Market Share by Country (2021-2026) Table 150. North America Biosimilars of Rituximab Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. North America Biosimilars of Rituximab Market Share Forecast by Country (2027-2032) Table 152. Europe Biosimilars of Rituximab Market Size Growth Rate (CAGR) by Country (K Pcs): 2021 VS 2025 VS 2032 Table 153. Europe Biosimilars of Rituximab Sales by Country (2021-2026) & (K Pcs) Table 154. Europe Biosimilars of Rituximab Sales Market Share by Country (2021-2026) Table 155. Europe Biosimilars of Rituximab Sales Forecast by Country (2027-2032) & (K Pcs) Table 156. Europe Biosimilars of Rituximab Sales Market Share Forecast by Country (2027-2032) Table 157. Europe Biosimilars of Rituximab Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Europe Biosimilars of Rituximab Market Size by Country (2021-2026) & (US$ Million) Table 159. Europe Biosimilars of Rituximab Market Share by Country (2021-2026) Table 160. Europe Biosimilars of Rituximab Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Europe Biosimilars of Rituximab Market Share Forecast by Country (2027-2032) Table 162. Asia-Pacific Biosimilars of Rituximab Market Size Growth Rate (CAGR) by Country (K Pcs): 2021 VS 2025 VS 2032 Table 163. Asia-Pacific Biosimilars of Rituximab Sales by Country (2021-2026) & (K Pcs) Table 164. Asia-Pacific Biosimilars of Rituximab Sales Market Share by Country (2021-2026) Table 165. Asia-Pacific Biosimilars of Rituximab Sales Forecast by Country (2027-2032) & (K Pcs) Table 166. Asia-Pacific Biosimilars of Rituximab Sales Market Share Forecast by Country (2027-2032) Table 167. Asia-Pacific Biosimilars of Rituximab Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Asia-Pacific Biosimilars of Rituximab Market Size by Country (2021-2026) & (US$ Million) Table 169. Asia-Pacific Biosimilars of Rituximab Market Share by Country (2021-2026) Table 170. Asia-Pacific Biosimilars of Rituximab Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Asia-Pacific Biosimilars of Rituximab Market Share Forecast by Country (2027-2032) Table 172. Latin America Biosimilars of Rituximab Market Size Growth Rate (CAGR) by Country (K Pcs): 2021 VS 2025 VS 2032 Table 173. Latin America Biosimilars of Rituximab Sales by Country (2021-2026) & (K Pcs) Table 174. Latin America Biosimilars of Rituximab Sales Market Share by Country (2021-2026) Table 175. Latin America Biosimilars of Rituximab Sales Forecast by Country (2027-2032) & (K Pcs) Table 176. Latin America Biosimilars of Rituximab Sales Market Share Forecast by Country (2027-2032) Table 177. Latin America Biosimilars of Rituximab Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Latin America Biosimilars of Rituximab Market Size by Country (2021-2026) & (US$ Million) Table 179. Latin America Biosimilars of Rituximab Market Share by Country (2021-2026) Table 180. Latin America Biosimilars of Rituximab Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Latin America Biosimilars of Rituximab Market Share Forecast by Country (2027-2032) Table 182. Middle East and Africa Biosimilars of Rituximab Market Size Growth Rate (CAGR) by Country (K Pcs): 2021 VS 2025 VS 2032 Table 183. Middle East and Africa Biosimilars of Rituximab Sales by Country (2021-2026) & (K Pcs) Table 184. Middle East and Africa Biosimilars of Rituximab Sales Market Share by Country (2021-2026) Table 185. Middle East and Africa Biosimilars of Rituximab Sales Forecast by Country (2027-2032) & (K Pcs) Table 186. Middle East and Africa Biosimilars of Rituximab Sales Market Share Forecast by Country (2027-2032) Table 187. Middle East and Africa Biosimilars of Rituximab Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 188. Middle East and Africa Biosimilars of Rituximab Market Size by Country (2021-2026) & (US$ Million) Table 189. Middle East and Africa Biosimilars of Rituximab Market Share by Country (2021-2026) Table 190. Middle East and Africa Biosimilars of Rituximab Market Size Forecast by Country (2027-2032) & (US$ Million) Table 191. Middle East and Africa Biosimilars of Rituximab Market Share Forecast by Country (2027-2032) Table 192. Key Raw Materials Table 193. Raw Materials Key Suppliers Table 194. Biosimilars of Rituximab Distributors List Table 195. Biosimilars of Rituximab Customers List Table 196. Research Programs/Design for This Report Table 197. Authors List of This Report Table 198. Secondary Sources Table 199. Primary Sources List of Figures Figure 1. Biosimilars of Rituximab Image Figure 2. Global Biosimilars of Rituximab Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biosimilars of Rituximab Market Size (2021-2032) & (US$ Million) Figure 4. Global Biosimilars of Rituximab Sales (2021-2032) & (K Pcs) Figure 5. 500mg Image Figure 6. Global 500mg Sales YoY Growth (2021-2032) & (K Pcs) Figure 7. 100mg Image Figure 8. Global 100mg Sales YoY Growth (2021-2032) & (K Pcs) Figure 9. Other Image Figure 10. Global Other Sales YoY Growth (2021-2032) & (K Pcs) Figure 11. Global Biosimilars of Rituximab Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Biosimilars of Rituximab Market Share by Type 2025 VS 2032 Figure 13. North America Biosimilars of Rituximab Sales Market Share in Volume by Type in 2025 Figure 14. North America Biosimilars of Rituximab Sales Market Share in Value by Type in 2025 Figure 15. Europe Biosimilars of Rituximab Sales Market Share in Volume by Type in 2025 Figure 16. Europe Biosimilars of Rituximab Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Biosimilars of Rituximab Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Biosimilars of Rituximab Sales Market Share in Value by Type in 2025 Figure 19. Latin America Biosimilars of Rituximab Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Biosimilars of Rituximab Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Biosimilars of Rituximab Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Biosimilars of Rituximab Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Biosimilars of Rituximab Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospital Pharmacy Image Figure 26. Global Hospital Pharmacy Sales YoY Growth (2021-2032) & (K Pcs) Figure 27. Retail Pharmacy Image Figure 28. Global Retail Pharmacy Sales YoY Growth (2021-2032) & (K Pcs) Figure 29. Global Biosimilars of Rituximab Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Biosimilars of Rituximab Market Share by Application 2025 VS 2032 Figure 31. North America Biosimilars of Rituximab Sales Market Share in Volume by Application in 2025 Figure 32. North America Biosimilars of Rituximab Sales Market Share in Value by Application in 2025 Figure 33. Europe Biosimilars of Rituximab Sales Market Share in Volume by Application in 2025 Figure 34. Europe Biosimilars of Rituximab Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Biosimilars of Rituximab Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Biosimilars of Rituximab Sales Market Share in Value by Application in 2025 Figure 37. Latin America Biosimilars of Rituximab Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Biosimilars of Rituximab Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Biosimilars of Rituximab Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Biosimilars of Rituximab Sales Market Share in Value by Application in 2025 Figure 41. North America Biosimilars of Rituximab Sales by Country: 2021 VS 2025 VS 2032 (K Pcs) Figure 42. North America Biosimilars of Rituximab Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Biosimilars of Rituximab Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Biosimilars of Rituximab Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Biosimilars of Rituximab Sales by Country: 2021 VS 2025 VS 2032 (K Pcs) Figure 46. Europe Biosimilars of Rituximab Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Biosimilars of Rituximab Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Biosimilars of Rituximab Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Biosimilars of Rituximab Sales by Country: 2021 VS 2025 VS 2032 (K Pcs) Figure 50. Asia-Pacific Biosimilars of Rituximab Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Biosimilars of Rituximab Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Biosimilars of Rituximab Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Biosimilars of Rituximab Sales by Country: 2021 VS 2025 VS 2032 (K Pcs) Figure 54. Latin America Biosimilars of Rituximab Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Biosimilars of Rituximab Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Biosimilars of Rituximab Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Biosimilars of Rituximab Sales by Country: 2021 VS 2025 VS 2032 (K Pcs) Figure 58. Middle East and Africa Biosimilars of Rituximab Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Biosimilars of Rituximab Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Biosimilars of Rituximab Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Biosimilars of Rituximab Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Biosimilars of Rituximab Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 500mg
  • 100mg
  • Other
Applications
  • Hospital Pharmacy
  • Retail Pharmacy
Companies covered
  • AryoGen Pharmed
  • Biocad
  • Cadila Pharmaceuticals
  • Celltrion
  • Dr Reddy’s Laboratories
  • Hetero Group
  • Innovent Biologics
  • Intas Biopharmaceuticals
  • Probiomed
  • TRPharma
  • Viatris
  • Zenotech Laboratories
  • Amgen
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Biosimilars of Rituximab Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Biosimilars of Rituximab Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Biosimilars of Rituximab Market by Type
  6. 1.3.1 500mg
  7. 1.3.2 100mg
  8. 1.3.3 Other
  9. 1.4 Global Biosimilars of Rituximab Market Size by Type
  10. 1.4.1 Global Biosimilars of Rituximab Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Biosimilars of Rituximab Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Biosimilars of Rituximab Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Biosimilars of Rituximab Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Biosimilars of Rituximab Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Biosimilars of Rituximab Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Biosimilars of Rituximab Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Biosimilars of Rituximab Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Biosimilars of Rituximab Industry Trends
  2. 2.2 Biosimilars of Rituximab Industry Drivers
  3. 2.3 Biosimilars of Rituximab Industry Opportunities and Challenges
  4. 2.4 Biosimilars of Rituximab Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Biosimilars of Rituximab Revenue (2021-2026)
  2. 3.2 Global Top Players by Biosimilars of Rituximab Sales (2021-2026)
  3. 3.3 Global Top Players by Biosimilars of Rituximab Price (2021-2026)
  4. 3.4 Global Biosimilars of Rituximab Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Biosimilars of Rituximab Major Company Production Sites & Headquarters
  6. 3.6 Global Biosimilars of Rituximab Company, Product Type & Application
  7. 3.7 Global Biosimilars of Rituximab Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Biosimilars of Rituximab Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Biosimilars of Rituximab Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Biosimilars of Rituximab Tier 1, Tier 2, and Tier 3
4 Biosimilars of Rituximab Regional Status and Outlook
  1. 4.1 Global Biosimilars of Rituximab Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Biosimilars of Rituximab Historic Market Size by Region
  3. 4.2.1 Global Biosimilars of Rituximab Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Biosimilars of Rituximab Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Biosimilars of Rituximab Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Biosimilars of Rituximab Forecasted Market Size by Region
  7. 4.3.1 Global Biosimilars of Rituximab Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Biosimilars of Rituximab Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Biosimilars of Rituximab Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Biosimilars of Rituximab by Application
  1. 5.1 Biosimilars of Rituximab Market by Application
  2. 5.1.1 Hospital Pharmacy
  3. 5.1.2 Retail Pharmacy
  4. 5.2 Global Biosimilars of Rituximab Market Size by Application
  5. 5.2.1 Global Biosimilars of Rituximab Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Biosimilars of Rituximab Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Biosimilars of Rituximab Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Biosimilars of Rituximab Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Biosimilars of Rituximab Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Biosimilars of Rituximab Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Biosimilars of Rituximab Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Biosimilars of Rituximab Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 AryoGen Pharmed
  2. 6.1.1 AryoGen Pharmed Company Information
  3. 6.1.2 AryoGen Pharmed Business Overview
  4. 6.1.3 AryoGen Pharmed Biosimilars of Rituximab Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 AryoGen Pharmed Biosimilars of Rituximab Product Portfolio
  6. 6.1.5 AryoGen Pharmed Recent Developments
  7. 6.2 Biocad
  8. 6.2.1 Biocad Company Information
  9. 6.2.2 Biocad Business Overview
  10. 6.2.3 Biocad Biosimilars of Rituximab Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Biocad Biosimilars of Rituximab Product Portfolio
  12. 6.2.5 Biocad Recent Developments
  13. 6.3 Cadila Pharmaceuticals
  14. 6.3.1 Cadila Pharmaceuticals Company Information
  15. 6.3.2 Cadila Pharmaceuticals Business Overview
  16. 6.3.3 Cadila Pharmaceuticals Biosimilars of Rituximab Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Cadila Pharmaceuticals Biosimilars of Rituximab Product Portfolio
  18. 6.3.5 Cadila Pharmaceuticals Recent Developments
  19. 6.4 Celltrion
  20. 6.4.1 Celltrion Company Information
  21. 6.4.2 Celltrion Business Overview
  22. 6.4.3 Celltrion Biosimilars of Rituximab Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Celltrion Biosimilars of Rituximab Product Portfolio
  24. 6.4.5 Celltrion Recent Developments
  25. 6.5 Dr Reddy’s Laboratories
  26. 6.5.1 Dr Reddy’s Laboratories Company Information
  27. 6.5.2 Dr Reddy’s Laboratories Business Overview
  28. 6.5.3 Dr Reddy’s Laboratories Biosimilars of Rituximab Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Dr Reddy’s Laboratories Biosimilars of Rituximab Product Portfolio
  30. 6.5.5 Dr Reddy’s Laboratories Recent Developments
  31. 6.6 Hetero Group
  32. 6.6.1 Hetero Group Company Information
  33. 6.6.2 Hetero Group Business Overview
  34. 6.6.3 Hetero Group Biosimilars of Rituximab Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Hetero Group Biosimilars of Rituximab Product Portfolio
  36. 6.6.5 Hetero Group Recent Developments
  37. 6.7 Innovent Biologics
  38. 6.7.1 Innovent Biologics Company Information
  39. 6.7.2 Innovent Biologics Business Overview
  40. 6.7.3 Innovent Biologics Biosimilars of Rituximab Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Innovent Biologics Biosimilars of Rituximab Product Portfolio
  42. 6.7.5 Innovent Biologics Recent Developments
  43. 6.8 Intas Biopharmaceuticals
  44. 6.8.1 Intas Biopharmaceuticals Company Information
  45. 6.8.2 Intas Biopharmaceuticals Business Overview
  46. 6.8.3 Intas Biopharmaceuticals Biosimilars of Rituximab Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Intas Biopharmaceuticals Biosimilars of Rituximab Product Portfolio
  48. 6.8.5 Intas Biopharmaceuticals Recent Developments
  49. 6.9 Probiomed
  50. 6.9.1 Probiomed Company Information
  51. 6.9.2 Probiomed Business Overview
  52. 6.9.3 Probiomed Biosimilars of Rituximab Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Probiomed Biosimilars of Rituximab Product Portfolio
  54. 6.9.5 Probiomed Recent Developments
  55. 6.10 TRPharma
  56. 6.10.1 TRPharma Company Information
  57. 6.10.2 TRPharma Business Overview
  58. 6.10.3 TRPharma Biosimilars of Rituximab Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 TRPharma Biosimilars of Rituximab Product Portfolio
  60. 6.10.5 TRPharma Recent Developments
  61. 6.11 Viatris
  62. 6.11.1 Viatris Company Information
  63. 6.11.2 Viatris Business Overview
  64. 6.11.3 Viatris Biosimilars of Rituximab Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Viatris Biosimilars of Rituximab Product Portfolio
  66. 6.11.5 Viatris Recent Developments
  67. 6.12 Zenotech Laboratories
  68. 6.12.1 Zenotech Laboratories Company Information
  69. 6.12.2 Zenotech Laboratories Business Overview
  70. 6.12.3 Zenotech Laboratories Biosimilars of Rituximab Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Zenotech Laboratories Biosimilars of Rituximab Product Portfolio
  72. 6.12.5 Zenotech Laboratories Recent Developments
  73. 6.13 Amgen
  74. 6.13.1 Amgen Company Information
  75. 6.13.2 Amgen Business Overview
  76. 6.13.3 Amgen Biosimilars of Rituximab Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Amgen Biosimilars of Rituximab Product Portfolio
  78. 6.13.5 Amgen Recent Developments
  79. 6.14 Teva
  80. 6.14.1 Teva Company Information
  81. 6.14.2 Teva Business Overview
  82. 6.14.3 Teva Biosimilars of Rituximab Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Teva Biosimilars of Rituximab Product Portfolio
  84. 6.14.5 Teva Recent Developments
7 North America by Country
  1. 7.1 North America Biosimilars of Rituximab Sales by Country
  2. 7.1.1 North America Biosimilars of Rituximab Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Biosimilars of Rituximab Sales by Country (2021-2026)
  4. 7.1.3 North America Biosimilars of Rituximab Sales Forecast by Country (2027-2032)
  5. 7.2 North America Biosimilars of Rituximab Market Size by Country
  6. 7.2.1 North America Biosimilars of Rituximab Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Biosimilars of Rituximab Market Size by Country (2021-2026)
  8. 7.2.3 North America Biosimilars of Rituximab Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Biosimilars of Rituximab Sales by Country
  2. 8.1.1 Europe Biosimilars of Rituximab Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Biosimilars of Rituximab Sales by Country (2021-2026)
  4. 8.1.3 Europe Biosimilars of Rituximab Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Biosimilars of Rituximab Market Size by Country
  6. 8.2.1 Europe Biosimilars of Rituximab Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Biosimilars of Rituximab Market Size by Country (2021-2026)
  8. 8.2.3 Europe Biosimilars of Rituximab Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Biosimilars of Rituximab Sales by Country
  2. 9.1.1 Asia-Pacific Biosimilars of Rituximab Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Biosimilars of Rituximab Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Biosimilars of Rituximab Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Biosimilars of Rituximab Market Size by Country
  6. 9.2.1 Asia-Pacific Biosimilars of Rituximab Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Biosimilars of Rituximab Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Biosimilars of Rituximab Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Biosimilars of Rituximab Sales by Country
  2. 10.1.1 South America Biosimilars of Rituximab Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Biosimilars of Rituximab Sales by Country (2021-2026)
  4. 10.1.3 South America Biosimilars of Rituximab Sales Forecast by Country (2027-2032)
  5. 10.2 South America Biosimilars of Rituximab Market Size by Country
  6. 10.2.1 South America Biosimilars of Rituximab Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Biosimilars of Rituximab Market Size by Country (2021-2026)
  8. 10.2.3 South America Biosimilars of Rituximab Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Biosimilars of Rituximab Sales by Country
  2. 11.1.1 Middle East and Africa Biosimilars of Rituximab Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Biosimilars of Rituximab Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Biosimilars of Rituximab Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Biosimilars of Rituximab Market Size by Country
  6. 11.2.1 Middle East and Africa Biosimilars of Rituximab Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Biosimilars of Rituximab Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Biosimilars of Rituximab Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Biosimilars of Rituximab Value Chain Analysis
  2. 12.1.1 Biosimilars of Rituximab Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Biosimilars of Rituximab Production Mode & Process
  7. 12.2 Biosimilars of Rituximab Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Biosimilars of Rituximab Distributors
  10. 12.2.3 Biosimilars of Rituximab Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst